BioXcel, common stock

BioXcel Therapeutics Announces Reverse Stock Split
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will effect a 1-for-16 reverse stock split of its common stock.
BioXcel Therapeutics Sets 1-for-16 Reverse Stock Split To Regain Nasdaq Listing
(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company's shares are expected to trade on a split adjusted basis beginning February 10, 2025.
Algorhythm Holdings announces 1-for-200 reverse stock split
Algorhythm Holdings, Inc. (NASDAQ:RIME), a Delaware-incorporated company specializing in phonograph records and prerecorded audio tapes and disks, announced today a significant change to its capital structure.
NewGenIvf to execute reverse stock split
NewGenIvf Group (NASDAQ:NIVF) is implementing a reverse stock split of all of its issued and unissued shares at an exchange ratio of one share for twenty shares. The company is primarily implementing the split to enable it to regain compliance with the Nasdaq $1.
Algorhythm Holdings Announces Date and Ratio of Reverse Stock Split
On January 14, 2025, the Board approved a one-for-two-hundred (1:200) Reverse Split of the Common Stock. The Company anticipates that beginning with the opening of trading on February 10, 2025, the Company’s Common Stock will trade on the Nasdaq Capital Market on a split-adjusted basis and will have a new CUSIP number, 829322502.
The State of Play for Reverse Stock Splits by Nasdaq- And Nyse-Listed Issuers
Introduction - Issuers listed on the Nasdaq Stock Market and the New York Stock Exchange (NYSE) often conduct reverse stock splits to
Palo Alto's Vincerx Pharma plans reverse stock split amid merger plans
The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.
Algorhythm announces 1-for-200 reverse stock split
Holdings announced the date of effectiveness and the ratio of a forthcoming reverse stock split of the Company’s Common Stock. On January 13, 2025, the Company announced, on a Current Report on Form 8-K,
24/7 Wall St2d
Stock Splits Matter: Here's What's Coming the Rest of February
Here is why companies split their stocks and why it matters. Plus, upcoming stock splits from Southern Copper, cannabis ETFs, ...
اخبار 2412h
Al-Baha says post-reverse stock split share capital is 218.30M
Al-Baha Investment and Development Co.said its post-reverse stock split share capital will be 218.30 million, instead of 2.18 ...
Hosted on MSN1d
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid Volatility
Tonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...